.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Baxter
Cipla
Medtronic
Queensland Health
UBS
Fuji
US Army
Cantor Fitzgerald
Daiichi Sankyo

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205931

« Back to Dashboard
NDA 205931 describes ACTICLATE, which is a drug marketed by Aqua Pharms Llc and Aqua Pharms and is included in two NDAs. It is available from two suppliers. Additional details are available on the ACTICLATE profile page.

The generic ingredient in ACTICLATE is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for NDA: 205931

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Dental and Oral Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 205931

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACTICLATE
doxycycline hyclate
 TABLET;ORAL 205931 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-6100 0591-6100-60 60 TABLET, FILM COATED in 1 BOTTLE (0591-6100-60)
ACTICLATE
doxycycline hyclate
 TABLET;ORAL 205931 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-6125 0591-6125-60 60 TABLET, FILM COATED in 1 BOTTLE (0591-6125-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 75MG BASE
Approval Date:Jul 25, 2014TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 150MG BASE
Approval Date:Jul 25, 2014TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
QuintilesIMS
Farmers Insurance
Cipla
McKinsey
Mallinckrodt
Chubb
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot